{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:49:47Z","timestamp":1744357787536},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.14219\/jada.archive.2008.0130","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:50:54Z","timestamp":1389228654000},"page":"152-157","source":"Crossref","is-referenced-by-count":9,"title":["Drug-induced paraparotid fat deposition in patients with HIV"],"prefix":"10.1016","volume":"139","author":[{"given":"Louis","family":"Mandel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Alfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9079","key":"10.14219\/jada.archive.2008.0130_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dube\u00e1","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.14219\/jada.archive.2008.0130_bib2","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"issue":"5","key":"10.14219\/jada.archive.2008.0130_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00126334-200108150-00004","article-title":"Lipodystrophic syndrome and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor","volume":"27","author":"Rakotoambinina","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.14219\/jada.archive.2008.0130_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/01.MLG.0000161838.22766.88","article-title":"HIV-associated cervicodorsal lipodystrophy: etiology and management","volume":"115","author":"Gold","year":"2005","journal-title":"Laryngoscope"},{"issue":"7","key":"10.14219\/jada.archive.2008.0130_bib5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.296.7.844","article-title":"Metabolic and skeletal complications of HIV infection: the price of success","volume":"296","author":"Morse","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.14219\/jada.archive.2008.0130_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"issue":"11","key":"10.14219\/jada.archive.2008.0130_bib7","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.14219\/jada.archive.2008.0130_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bjps.2005.12.047","article-title":"Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants","volume":"59","author":"Mori","year":"2006","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"12","key":"10.14219\/jada.archive.2008.0130_bib9","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/00002030-200308150-00018","article-title":"Anterior neck fat deposition in lipodystrophy syndrome; a new variant on a theme?","volume":"17","author":"Woolley","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.14219\/jada.archive.2008.0130_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2310\/6650.2005.00001","article-title":"Regional body fat distribution in HIV-infected patients with lipodystrophy","volume":"53","author":"Dinges","year":"2005","journal-title":"J Investig Med"},{"issue":"2","key":"10.14219\/jada.archive.2008.0130_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tips.2004.12.005","article-title":"Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral\u2013induced mitochondrial toxicity","volume":"26","author":"Villarroya","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"15","key":"10.14219\/jada.archive.2008.0130_bib12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0755-4982(05)84124-7","article-title":"Lipid disorders in patients with HIV-induced diseases","volume":"34","author":"Chanu","year":"2005","journal-title":"Presse Med"},{"issue":"10","key":"10.14219\/jada.archive.2008.0130_bib13","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitiors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"issue":"10","key":"10.14219\/jada.archive.2008.0130_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosigliatazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Int Med"},{"issue":"4","key":"10.14219\/jada.archive.2008.0130_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV-negative men","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS"},{"issue":"15","key":"10.14219\/jada.archive.2008.0130_bib16","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1\u2013infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"issue":"9170","key":"10.14219\/jada.archive.2008.0130_bib17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction and natural course of HIV-1 protease-inhibitor\u2013associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"issue":"18","key":"10.14219\/jada.archive.2008.0130_bib18","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","article-title":"Increased risk of lipoatrophy under stavudine in HIV-1\u2013infected patients: results of substudy from a comparative trial","volume":"16","author":"Joly","year":"2002","journal-title":"AIDS"},{"issue":"22","key":"10.14219\/jada.archive.2008.0130_bib19","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/archinte.162.22.2621","article-title":"Incidence of adipose tissue alterations in front-line antiretroviral therapy: the LipolCoNA Study","volume":"162","author":"Galli","year":"2002","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.14219\/jada.archive.2008.0130_bib20","first-page":"191","article-title":"Switching strategies to improve lipid profile and morphologic changes","volume":"8","author":"Barragan","year":"2006","journal-title":"AIDS Rev"},{"issue":"3","key":"10.14219\/jada.archive.2008.0130_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/135965350300800306","article-title":"Fat distribution and metabolic abnormalities in HIV-infected patients on first combination of antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor","volume":"8","author":"Domingo","year":"2003","journal-title":"Antivir Ther"},{"issue":"9256","key":"10.14219\/jada.archive.2008.0130_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1\u2013infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.14219\/jada.archive.2008.0130_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","article-title":"Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"issue":"1","key":"10.14219\/jada.archive.2008.0130_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","article-title":"Antiretroviral therapy and the lipodystrophy syndrome","volume":"6","author":"John","year":"2001","journal-title":"Antivir Ther"},{"issue":"3","key":"10.14219\/jada.archive.2008.0130_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/135965350100600301","article-title":"Antiretroviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis","volume":"6","author":"Nolan","year":"2001","journal-title":"Antivir Ther"},{"issue":"3","key":"10.14219\/jada.archive.2008.0130_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1079-2104(00)70092-8","article-title":"Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy","volume":"89","author":"Patton","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"7","key":"10.14219\/jada.archive.2008.0130_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"issue":"supplement 1","key":"10.14219\/jada.archive.2008.0130_bib28","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/QAI.0b013e31806007ed","article-title":"Metabolic issues associated with protease inhibitors","volume":"45","author":"Moyle","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.14219\/jada.archive.2008.0130_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART-associated lipodystrophy: a randomized double-blind placebo-controlled study","volume":"8","author":"Sutinen","year":"2003","journal-title":"Antivir Ther"},{"issue":"9407","key":"10.14219\/jada.archive.2008.0130_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714606802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714606802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T15:32:55Z","timestamp":1688916775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817714606802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0002817714606802"],"URL":"https:\/\/doi.org\/10.14219\/jada.archive.2008.0130","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}